Back to search

Germany· DE-A57-556568f20f1e1b47

Teicoplanin Seacross

A teicoplanin product containing teicoplanin, registered in Germany by Seacross Pharma (Europe) Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC J01XA02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedTeicoplanin SeacrossATCJ01XA02REGISTER NO.DE-A57-556568f20f1e1b…PACKS LISTED0CHECKEDAugust 5, 2026

Where it is registered

Teicoplanin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose

Teicoplanin · ATC J01XA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Teicoplanin
Manufacturer
Seacross Pharma (Europe) Ltd
Country
Germany (DE)
ATC code
J01XA02
ATC class
Teicoplanin
Defined daily dose
0.4 g, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
August 5, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Teicoplanin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teicoplanin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Teicoplanin Accord, Teicoplanin Altan
  • Belgium · Targocid, Teicoplanin Bradex
  • Bulgaria · Планитек, Планицид
  • Cyprus · Talinac, Teicoplanin Aptapharma
  • Czechia · Targocid, Teicoplanin Aptapharma
  • Denmark · Targocid, Teicoplanin Demo S.A.
  • Spain · Targocid, Teicoplanina Accord
  • Finland · Targocid, Teicoplanin Demo S.A.
  • France · Targocid, Teicoplanine Altan
  • United Kingdom (Northern Ireland) · Targocid, Teicoplanin
  • Greece · Talinac, Targocid
  • Croatia · Targocid, Teikoplanin Aptapharma
  • Hungary · Targocid, Teicoplanin Anfarm
  • Ireland · Targocid, Teicoplanin Hikma
  • Italy · Planicid, Targosid
  • Luxembourg · Targocid
  • Malta · Targocid, Teicoplanin Anfarm
  • Netherlands · Targocid, Teicoplanin Sun
  • Norway · Teicoplanin Demo S.A.
  • Poland · Targocid, Teicoplanin Altan
  • Portugal · Teicoplanina Accord, Teicoplanina Altan
  • Romania · Targocid, Teicoplanină Aptapharma
  • Sweden · Targocid, Teicoplanin Bradex
  • Slovenia · Targocid, Teikoplanin Aptapharma
  • Slovakia · Targocid, Teicoplanin Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a94f4624-b143-4b25-9b58-2933969ed969
GET /v1/drugs/a94f4624-b143-4b25-9b58-2933969ed969?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intramuscular Use, Intravenous Use, Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Teicoplanin",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about teicoplanin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.